Stanton, John

Stanton, John was paid $6.17 by Medicaid between Nov 2018 and Sep 2020, across 9 billing codes. Its largest line is J3300, Injection, triamcinolone acetonide, preservative free, 1 mg — 41% of everything it billed.

33Billing provider infoSTANTON, JOHN
CLARKSVILLE, TN 37040

33aNPI1245233063assigned 05/24/2005

33bProvider typeSpecialist

28Total paid$6.17

24GClaims809

24DCodes billed9

24AFirst – last monthNov 2018 – Sep 2020

Compared with peers

Next to other Specialist providers in Tennessee

Rank by total paid#245 of 252

Median peer was paid$57K

This provider vs. median0.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

OIG exclusionListed on the federal exclusion list (10/19/2023).

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	612	$3.65
2019	152	$0.00
2020	45	$2.52

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
J3300	Injection, triamcinolone acetonide, preservative free, 1 mg	41%	13	12	$2.52
96120		37%	85	80	$2.30
96103		22%	85	80	$1.35
G0396	Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes	0%	99	94	$0.00
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	0%	233	206	$0.00
96146		0%	15	15	$0.00
J1100	Injection, dexamethasone sodium phosphate, 1 mg	0%	12	12	$0.00
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	0%	133	122	$0.00
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	0%	134	122	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.